Clearwater Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Clearwater Capital Advisors's LLY Position: Q1 2026 in Review
Clearwater Capital Advisors increased its Eli Lilly (LLY) stake by 1.7% in Q1 2026, buying an estimated $18.2K and bringing the position to 1,102 shares worth $1.01M. The position accounts for 0.08% of the portfolio, ranked #72.
Clearwater Capital Advisors first reported a position in LLY in Q1 2018 and has held it in 23 quarters since. The position peaked at $1.16M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Clearwater Capital Advisors held 1,102 shares of Eli Lilly worth $1.01M as of Q1 2026.
- Clearwater Capital Advisors bought 18 Eli Lilly shares in Q1 2026, an estimated $18.2K.
- Eli Lilly made up 0.08% of Clearwater Capital Advisors's portfolio in Q1 2026, its #72 holding.
- Clearwater Capital Advisors first reported a position in Eli Lilly in Q1 2018 and has held it in 23 quarters since.
- Clearwater Capital Advisors's Eli Lilly position peaked at $1.16M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Clearwater Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.